<DOC>
	<DOCNO>NCT02480296</DOCNO>
	<brief_summary>The purpose study establish safety , tolerability , pharmacokinetics pharmacodynamics multiple dos MYK-461 human subject . This randomized , double-blind , placebo-controlled , sequential group , multiple ascending ( oral tablet ) dose study healthy volunteer age 18-55 year .</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics Pharmacodynamics Multiple Ascending Oral Doses MYK-461 Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Normal body mass index ( BMI ) Normal LVEF Normal electrocardiogram ( ECG ) Females must non pregnant , non lactating , sexually active , use acceptable birth control method time first dose 3 month last dose study drug Any structural abnormality echocardiography Positive result HIV test and/or seropositive HCV HBV</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>